← Open Payments lookup

SHAMARUKH KABIR: Open Payments

NPI 1851826077 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,400 in 95 payments from 16 companies in 2025. Trend: 2023 $1,723 · 2024 $1,734 · 2025 $2,400

Food & beverage: $2,400
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$566
Otsuka America Pharmaceutical, Inc.17$418
E.R. Squibb & Sons, L.L.C.7$270
ABBVIE INC.14$266
Axsome Therapeutics, Inc.8$200
Supernus Pharmaceuticals, Inc.3$156
Neurocrine BioSciences, Inc.6$148
Janssen Pharmaceuticals, Inc4$112
Teva Pharmaceuticals USA, Inc.4$97
Vanda Pharmaceuticals Inc.3$53

Products named: CAPLYTA, REXULTI, COBENFY, VRAYLAR, Auvelity, Qelbree, INGREZZA, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.